In many instances of medication delivery, the medicament must be stored in a cold environment in order to prevent spoilage. However, injection of cold medication may be painful or uncomfortable to a patient. Moreover, certain medicaments must be delivered at certain temperatures in order to maximize efficacy. In order to determine whether the medicament in a particular delivery device has reached proper temperature after being removed from cold storage, a ready-to-use indicator system may be advantageous.
Embodiments may provide an injection system, which may comprise an injector, which may further comprise a dispensing mechanism configured to dispense a medicament; a ready-to-use indicator that may further comprise a controller configured to interact with the ready-to-use indicator and an audio and/or visual indicator; a temperature sensor; and a temperature analog having similar thermodynamic properties of the medicament; wherein the temperature sensor is configured to detect a temperature of the temperature analog which represents the dynamic temperature of the medicament as the medicament is heated or cooled; wherein the temperature sensor is configured to communicate the detected temperature to the controller and to alert the controller when a preset temperature is reached; wherein the ready-to-use indicator is configured to alert a user when the preset temperature is reached, signifying the medicament is thermally ready to be delivered by the dispensing mechanism; and wherein the audio and/or visual indicator is configured to display one or more notifications to the user.
Embodiments may further provide a system wherein the injector may further comprise an initiator configured to interact with the controller to instruct the ready-to-use indicator to begin notification.
Embodiments may further provide a system wherein the initiator may be a battery isolator configured to isolate a battery from the injector.
Embodiments may further provide a system wherein the initiator may be a button.
Embodiments may further provide a system wherein the ready-to-use indicator may further comprise a pre-programmed timer; wherein the pre-programmed tinier may be configured to count down from a predetermined time once an initiation signal has been received and to communicate a zero reading to the controller.
Embodiments may further provide a system wherein the temperature analog comprises one of more of a gas, liquid, or gel and the system further comprises a syringe configured to inject the one or more of the gas, liquid, or gel into the temperature analog through a body of the injector.
Embodiments may further provide a system wherein the temperature sensor may be further configured to detect an ambient temperature and communicate the ambient temperature to the controller.
Embodiments may further provide a system a system wherein the audio and/or visual indicator may further comprise one or more of an LED, a display, a speaker, or a vibration motor.
Embodiments may further provide a method of using an injector with a ready-to-use indicator, which may comprise activating a temperature sensor after the injector has been removed from a cold storage location; detecting the temperature of a temperature analog corresponding to the temperature of the medicament, and emitting a notification from the ready-to-use indicator that a preset temperature of the temperature analog has been reached, thus indicating that the medicament is also at the preset temperature and thermally ready for injection.
Embodiments may further provide a method that may further comprise filling the temperature analog with the one or more of the gas, liquid, or gel using a syringe.
Embodiments may further provide a method that may further comprise detecting an ambient temperature using a second temperature sensor; and setting the preset temperature as the ambient temperature.
Embodiments may further provide a method that may further comprise removing a battery isolator to activate the temperature sensor.
Various aspects of the disclosure will now be described in connection with the attached drawings, in which:
It accordance with various aspects of the present disclosure, an injector with ready-to-use indicator may be a component for injection devices with refrigerated storage that may provide visual and/or audio indications to device users when a desired warm up time has been reached and the internal temperature of the device, and more specifically the injectable drug (medicament) which is to be administered, has reached an acceptable temperature for injection. The visual or audio indicators may be integrated into various types of injector systems and may be used in any form of injection device.
Once the injector 101 is removed from cold storage, it may determine whether the medicament 102 is at a proper temperature to be delivered. In one aspect, a pre-programmed timer 108 may interact with a controller 105 in order to notify a user when the drug is ready for use (i.e., when the drug has reached acceptable temperature). The timer may be activated following removal of the device from cold storage through the activation of an initiator 106. The initiator 106 may include a battery isolator or a button, which may be incorporated into a light guide, and which may send the ready-to-use indicator an initiation signal.
The timer 108 may be pre-programmed based on the type of medicament 102 to be delivered. Once activated, the pre-programmed timer may start to count down until predetermined time for the drug to warm up has elapsed. The time duration necessary to warm up to the appropriate range of temperature may be determined based on the requirements of particular drugs or may be provided in standard intervals. For example, a thicker or more viscous medicament may require a longer duration out of cold storage before delivery, while a thinner or less viscous medicament may require a shorter time out of cold storage. In one aspect, the user may program the tinier 108. In another aspect, the timer 108 may be preprogrammed by the manufacturer prior to sale or delivery.
The timer 108 may communicate with a central controller 105 in order to provide timing and/or alarm updates. The controller 105, in turn, may send commands to an audio and/or visual indicator 109 in order to provide notifications to the user regarding the medicament's 102 readiness. In one aspect, the notifications may be presented to the user through one or more of a combination of visual cues provided by a display and/or one or more LEDs 110, audio cues provided by a speaker 111, and/or tactile feedback provided by a vibration motor 112. A battery 113, timer 108, and audio and/or visual indicator 109 may be contained in the injector 101 through the use of a printed circuit board (PCB) or other circuit board.
Returning to
The temperature sensor 107 may be activated following removal of the injector 101 from cold storage through the activation of the initiator 106. Once activated, the temperature sensor 107 may continuously monitor the temperature of the medicament and/or a temperature analog of the medicament until the temperature reaches the target temperature. In one aspect, the target temperature may be programmed by the user, or may be preprogrammed by the manufacturer prior to sale or delivery of the injector 107. In a further aspect, the temperature sensor 107 may also monitor the ambient temperature at the injector's 101 current location and may use the ambient temperature as the desired target temperature for the medicament.
In another embodiment not shown, the temperature analog 402 may be directly mounted to the PCB 404. In such a case, the temperature sensor 401 may be mounted in between the temperature analog 402 and the PCB 404, or the temperature sensor 401 may be potted inside a cavity of the temperature analog 402. In further embodiments, the temperature analog 402 may be comprised of dissimilar metals, such as to have thermal electric properties of a thermal couple. In such a case, the temperature analog 402 would itself operate as a temperature sensor. Optionally, a second temperature sensor (not shown) may be used to measure the ambient temperature of the surroundings. The controller may optionally use the ambient temperature to help determine a temperature at which the medicament is to be dispensed.
These aspects are not meant to be limiting. For different injector systems, the positioning and size of the circuit may vary. It will be appreciated by persons skilled in the art that the present disclosure is not limited by what has been particularly shown and described hereinabove. Rather the scope of the present disclosure includes both combinations and sub-combinations of various features described hereinabove as well as modifications and variations which would occur to persons skilled in the art upon reading the foregoing description and which are not in the prior art.
This application is a continuation of U.S. application Ser. No. 16/500,878 filed Oct. 4, 2019, which is a section 371 of International Application No. PCT/US18/026556, filed Apr. 6, 2018, which was published on Oct. 11, 2018 under International Publication No. WO 2018/187744 A1, and which claims priority to U.S. Provisional Patent Application No. 62/482,496, filed Apr. 6, 2017, the contents of each of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
6810350 | Blakley | Oct 2004 | B2 |
8226610 | Edwards et al. | Jul 2012 | B2 |
8827964 | Boyd et al. | Sep 2014 | B2 |
9181008 | Milan | Nov 2015 | B2 |
9278177 | Edwards et al. | Mar 2016 | B2 |
9470587 | Greene | Oct 2016 | B1 |
10792435 | Davis | Oct 2020 | B2 |
20020188419 | Slate et al. | Dec 2002 | A1 |
20070239116 | Follman et al. | Oct 2007 | A1 |
20080312604 | Boesen | Dec 2008 | A1 |
20090024112 | Edwards et al. | Jan 2009 | A1 |
20090030366 | Hochman | Jan 2009 | A1 |
20100211005 | Edwards | Aug 2010 | A1 |
20140155827 | Ostrander et al. | Jun 2014 | A1 |
20150011965 | Cabiri | Jan 2015 | A1 |
20150061389 | Song et al. | Mar 2015 | A1 |
20150080810 | Henderson et al. | Mar 2015 | A1 |
20160259913 | Yu | Sep 2016 | A1 |
20170224934 | Shultz et al. | Aug 2017 | A1 |
20170348478 | Tobescu | Dec 2017 | A1 |
20200397977 | Keitzmann | Dec 2020 | A1 |
Number | Date | Country |
---|---|---|
205287099 | Jun 2016 | CN |
3100754 | Dec 2016 | EP |
2014516667 | Jul 2014 | JP |
2015061389 | Apr 2015 | WO |
WO 2016033507 | Mar 2016 | WO |
WO-2017090019 | Jun 2017 | WO |
Entry |
---|
Extended European Search Report dated Aug. 5, 2020 in European Application No. 18780556.9. |
Int'l Search Report and Written Opinion dated Jul. 12, 2018 in Int'l Application No. PCT/US2018/026556. |
International Preliminary Report on Patentability dated Oct. 8, 2019 in Int'l Application No. PCT/US2018/026556. |
Office Action dated Mar. 17, 2020 in JP Application No. 2019-554804. |
Number | Date | Country | |
---|---|---|---|
20200360617 A1 | Nov 2020 | US |
Number | Date | Country | |
---|---|---|---|
62482496 | Apr 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16500878 | US | |
Child | 16984941 | US |